Tenon Medical, Inc.

Name: Tenon Medical, Inc. standardized financial statements, quarterly
Creator: Listed

TNONNasdaqCIK 1560293HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.3m, Q2 FY2026

Operating income−$3.4m, Q2 FY2026

Net income−$4.0m, Q2 FY2026

Tenon Medical, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	944	808	719	901	887	770	726	564	1,173	1,481	1,379	1,279
Cost of revenue	$k	409	249	249	431	469	417	403	319	400	464	434	465
Gross profit	$k	535	559	470	470	418	353	323	245	773	1,017	945	814
Research and development	$k	737	691	669	708	657	569	691	503	428	527	662	768
Operating income	$k	(3,378)	(3,141)	(3,506)	(3,872)	(3,215)	(3,173)	(3,677)	(2,857)	(3,392)	(2,866)	(3,280)	(3,354)
Interest expense	$k	4.0	17.0	34.0	0.0	0.0	0.0	not reported	not reported	not reported	not reported	176	852
Net income	$k	(3,332)	(3,134)	(3,576)	(3,826)	(3,184)	(3,087)	(3,616)	(2,769)	(3,339)	(2,832)	(3,476)	(4,050)
Diluted EPS	$ per share	(11.69)	not reported	(10.02)	(8.16)	(3.63)	not reported	1.01	(12.76)	(0.40)	not reported	0.31	(12.35)
Basic EPS	$ per share	(11.69)	not reported	(10.02)	(8.16)	(3.63)	not reported	(1.01)	(12.76)	(0.40)	not reported	(0.31)	(12.35)

Balance sheet

Cash and equivalents$1.7m, Q2 FY2026

Shareholders' equity−$1.7m, Q2 FY2026

Tenon Medical, Inc., balance sheet, quarterly
Line item	Unit	FY20232023-12-31	Q1 FY20242024-03-31	period not labelled2024-05-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	2.4	4.4	not reported	2.0	9.2	6.5	10.3	7.8	3.4	3.8	4.6	1.7
Current assets	$m	3.9	6.0	not reported	4.1	11.2	8.2	12.0	9.9	6.5	6.8	7.6	4.8
Total assets	$m	6.3	8.0	not reported	6.0	13.0	9.8	13.4	11.1	10.4	10.8	12.8	9.9
Current liabilities	$m	3.1	2.3	not reported	3.4	3.2	1.9	2.2	2.6	3.0	3.2	7.4	8.3
Total liabilities	$m	5.6	4.4	not reported	5.2	4.8	3.9	4.0	4.4	5.6	5.7	10.9	11.7
Shareholders' equity	$m	0.8	3.6	0.8	0.8	8.2	6.0	9.4	6.7	4.8	5.0	1.9	(1.7)

Cash flow

Operating cash flow−$2.8m, Q2 FY2026

Capital expenditure$172.0k, Q2 FY2026

Tenon Medical, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(3,153)	(2,278)	(2,338)	(2,420)	(2,343)	(2,777)	(2,483)	(2,214)	(3,824)	(2,224)	(2,960)	(2,758)
Capital expenditure	$k	57.0	92.0	119	0.0	104	(37.0)	not reported	not reported	(111)	192	56.0	172

Diluted shares (weighted)328, Q2 FY2026

Tenon Medical, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	k shares	1.1	1.1	1.3	0.3	0.4	0.5	0.9	3.6	0.2	8.3	11.3	0.3

Shares outstanding: 667,047 at Aug 13, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.